Nanoparticle vaccines against respiratory viruses

Area of Science:

• Virology
• Immunology
• Vaccinology

Background:

• Influenza virus, respiratory syncytial virus (RSV), and parainfluenza type 3 virus (PI-3V) are key causes of severe lower respiratory tract disease in humans and animals.
• Infections begin in the upper respiratory tract and can progress to life-threatening conditions like pneumonia in the lower respiratory tract.

Purpose of the Study:

• To explore the potential of nanoparticle vaccines for preventing viral respiratory infections.
• To enhance vaccine efficacy, particularly in vulnerable populations like infants.

Main Methods:

• Development of nanoparticle vaccines containing antigenic components from influenza, RSV, and PI-3V.
• Evaluation of the capacity of these nanoparticle vaccines to elicit mucosal and systemic immune responses.

Main Results:

• Nanoparticle vaccines successfully stimulated both mucosal and systemic immunity.
• This immune stimulation demonstrated potential in preventing the spread of infection to the lower respiratory tract.

Conclusions:

• Nanoparticle vaccine technology offers a promising strategy for combating major viral respiratory pathogens.
• Encapsulating viral proteins in nanoparticles may overcome challenges in infant vaccination due to maternal antibodies, improving efficacy.